Caricamenti by Nalini Rajamannan

R_CHI Northwestern University IRB EIR Dtd 8-8-08_Redacted

R_CHI Northwestern University IRB EIR Dtd 8-8-08_Redacted

2023-12-20 Schill Neilson Barris Jameson Ltr Signed

Letter President Schill 11-7-2022 Final

FDA Letter 7-16-09 Vlahoulis

Detiologix_510k

Senator lugar

ORIRajamannanResponse_080918-2

AATS Abstract 2007 2

Letter President Schill 11-7-2022 Final

2023-12-20 Schill Neilson Barris Jameson Ltr Signed

R_CHI Northwestern IRB Exh 15 Dtd 8-8-08_Redacted-6

Meeting_Dean_Lowe_3_12_2011[1]

SJIletter Northwestern University 2014

Myxo Patent Office Action

FDA Determination to inform patients

FDA Letter 7-16-09 Vlahoulis

European_Website_Edwards Lifesciences Highlights Newest Heart Valve Innovations at AATS 2007

Testimony Maisel

ORIRajamannanResponse_080918

VlahoulisResponse_080918

FDA Response to Senator Grassley- 2009

Gmail - RE

American Association of Thoracic Surgeons

2021.06.18 Ltr Michael Chin

AATS Abstract 2007 2

ORIRajamannanResponse_080918

R_CHI Northwestern University IRB EIR Dtd 8-8-08_Redacted

371297298 Cardiovascular Review Jan 2007

Executive Summary FINAL

Fdaaffidavit Exhibit 1

CHI Completion Letter 2018-9249

FDA Response to Senator Grassley- 2009

556240932-2011-06-17-Nw-Irb-Resp-Ltr

First in Human Use_Page_14

R_CHI_Northwestern IRB Exh 14 Dtd 8-8-08_Redac

Gmail - Fwd

FDA Warning Letter 3 2010

FDA Recall Documents

FDA DETERMINATION

R_CHI Northwestern IRB Exh 15 Dtd 8-8-08_Redacted

R_CHI Northwestern University IRB EIR Dtd 8-8

AATS Abstract May 07

12-6-2019_Northwestern University General Counsel FDA Opinion

ORIRajamannanResponse_080918

EW-S-20000168

FDA Letter Vlahoulis

FDA Warning Letter 3 2010

FDA letter